Timothy S. Nelson - Nov 19, 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role: Director
Signature: /s/ John Leaman, M.D. as attorney-in-fact
Stock symbol: IMPL
Transactions as of: Nov 19, 2021
Transactions value $: $107,554
Form type: 4
Date filed: 11/22/2021, 04:05 PM
Previous filing: Jul 13, 2021
Next filing: Jun 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMPL	Common Stock	Purchase	$108K	+10K		$10.76	10K	Nov 19, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.71 to $10.85 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.71 to $10.85 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.